Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer. - Surana R; Morgado M; Somasundaram A; Bockorny B; Weekes CD; Coleman EC; Bird A; Wang J; Williams HL; Zheng H; Brais LK; Saxena N; et al. (JCO precision oncology, 2025)